Afficher la couverture 'Place de l’imagerie moléculaire dans la prise en charge du cancer de la prostate | Rousseau, Chloé' en grand format
/5

0 avis

Place de l’imagerie moléculaire dans la prise en charge du cancer de la prostate

Archive ouverte

Rousseau, Chloé | Le Thiec, M. | Maucherat, B. | Frindel, M. | Fleury, V.

Edité par CCSD ; Elsevier Masson -

International audience. In the management of prostate cancer in recent years, innovative therapies have appeared requiring precise and reliable disease detection. In 2021, new generation imaging (PET/CT, multiparametric MRI, PET/MRI) have their place at all stages of the prostate cancer natural history to help target the lesion(s) and guide therapy and improve the results obtained. PSMA PET/CT is currently the leader in this type of imaging with a complete offer during the disease: both from diagnosis, to recurrence or in the oligo-metastatic and metastatic stage resistant to castration with a pivotal role in the PSMA theranostic approach. However, multiparametric MRI also has many detection advantages when the prostate is left in place, which suggests the potential major benefit of hybrid PSMA PET/MRI imaging.

Suggestions

Du même auteur

First results of molecular imaging (FDG and FES) in prospective study for selecting second line hormonotherapy in estrogen receptors positive metastatic breast cancer patients

Archive ouverte | Maucherat, B. | CCSD

International audience. Aim/Introduction: About 70% of primitive breast cancers had positive estrogen receptors (ER) and may benefit from hormonotherapy. However, ER expression in breast cancer metastases is heterog...

68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT : impact on therapeutic decision-making and biomarker changes

Archive ouverte | Rousseau, Caroline | CCSD

International audience. Aim/Introduction: The aim of this retrospective study was to investigate the impact of 68Ga-PSMA-11 PET/CT on current management of recurrence prostate cancer patients with negative PET/CT F-...

Preliminary results of 68Ga-PSMA PET/CT prospective study in prostate cancer occult recurrence patients : diagnostic performance and impact on therapeutic decision-making

Archive ouverte | Rousseau, Caroline | CCSD

International audience. Introduction: The aim of this prospective study was to investigate the impact of 68Ga-PSMA-11 PET/CT on current management of prostate cancer patients with occult biochemical recurrence (BCR)...

Chargement des enrichissements...